Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY)

Drug and Alcohol Dependence

Volumn 90, Issue 2-3, 2007, Pages 297-300

  Sparta, Dennis R ^a   Fee, Jon R ^a   Knapp, Darin J ^b   Breese, George R ^b   Thiele, Todd E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Anxiety; Mice; Neuropeptide Y; Withdrawal

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DIET; FEMALE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANXIETY DISORDERS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; MALE; MICE; MICE, MUTANT STRAINS; NEUROPEPTIDE Y;

MUS;

EID: 34548039480     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.04.001     Document Type: Article

References (34)

1. Badia-Elder N.E., Stewart R.B., Powrozek T.A., Roy K.F., Murphy J.M., and Li T.K. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and nonpreferring (NP) rats. Alcohol. Clin. Exp. Res. 25 (2001) 386-390
2. Berglund M.M., Hipskind P.A., and Gehlert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. 228 (2003) 217-244
3. Bibb J.L., and Chambless D.L. Alcohol use and abuse among diagnosed agoraphobics. Behav. Res. Ther. 24 (1986) 49-58
4. Breese G.R., Knapp D.J., and Overstreet D.H. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology 29 (2004) 470-482
5. Breese G.R., Overstreet D.H., and Knapp D.J. Conceptual framework for the etiology of alcoholism-a "kindling"/stress hypothesis. Psychopharmacology 178 (2005) 367-380
6. Cappell H., and Herman C.P. Alcohol and tension reduction. A review. Q. J. Stud. Alcohol 33 (1972) 33-64
7. Colmer W.F., and Wahlestedt C. The Biology of Neuropeptide Y and Related Peptides (1993), Humana Press, Totowa, NJ
8. Cornelius J.R., Bukstein O., Salloum I., and Clark D. Alcohol and psychiatric comorbidity. Recent Dev. Alcohol. 16 (2003) 361-374
9. Dumont Y., Martel J.C., Fournier A., St-Pierre S., and Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38 (1992) 125-167
10. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-418
11. Gray T.S., and Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38 (1986) 389-401
12. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., and Britton K.T. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993) 357-363
13. Heilig M., Soderpalm B., Engel J.A., and Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98 (1989) 524-529
14. Henderson N.D., Turri M.G., DeFries J.C., and Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav. Genet. 34 (2004) 267-293
15. Homanics G.E., Le N.Q., Kist F., Mihalek R., Hart A.R., and Quinlan J.J. Ethanol tolerance and withdrawal responses in GABA(A) receptor alpha 6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice. Alcohol. Clin. Exp. Res. 22 (1998) 259-265
16. Knapp D.J., Overstreet D.H., Moy S.S., and Breese G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32 (2004) 101-111
17. Koob G.F. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27 (2003) 232-243
18. Moy S.S., Knapp D.J., Criswell H.E., and Breese G.R. Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology 131 (1997) 354-360
19. Moy S.S., Knapp D.J., Duncan G.E., and Breese G.R. Enhanced ultrasonic vocalization and Fos protein expression following withdrawal: effects of flumazenil. Psychopharmacology 152 (2000) 208-215
20. Overstreet D.H., Knapp D.J., and Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 26 (2002) 1259-1268
21. Overstreet D.H., Knapp D.J., and Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 77 (2004) 405-413
22. Palmiter R.D., Erickson J.C., Hollopeter G., Baraban S.C., and Schwartz M.W. Life without neuropeptide Y. Recent Prog. Horm. Res. 53 (1998) 163-199
23. Pandey S.C., Carr L.G., Heilig M., Ilveskoski E., and Thiele T.E. Neuropeptide Y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol. Clin. Exp. Res. 27 (2003) 149-154
24. Pandey S.C., Roy A., and Zhang H. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27 (2003) 396-409
25. Pandey S.C., Zhang H., Roy A., and Xu T. Deficits in amygdaloid cAMP-responsive elements-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest. 115 (2005) 2697-2699
26. Roy A., and Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol. Clin. Exp. Res. 26 (2002) 796-803
27. Sajdyk T.J., Vandergriff M.G., and Gehlert D.R. Amygdalar neuropeptide Y Y-1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 368 (1999) 143-147
28. Schuckit M.A., and Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship?. Am. J. Psychiatry 151 (1994) 1723-1734
29. Thiele T.E., Koh M.T., and Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 22 (2002) RC208
30. Thiele T.E., Marsh D.J., Ste. Marie L., Bernstein I.L., and Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396 (1998) 366-369
31. Thiele T.E., Miura G.I., Marsh D.J., Bernstein I.L., and Palmiter R.D. Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacol. Biochem. Behav. 67 (2000) 683-691
32. Thiele T.E., Sparta D.R., Hayes D.M., and Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38 4 (2004) 235-243
33. Turri M.G., Datta S.R., DeFries J., Henderson N.D., and Flint J. QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Curr. Biol. 11 (2001) 725-734
34. Winer B.J., Brown D.R., and Michels K.M. Statistical Principles in Experimental Design (1991), McGraw-Hill, Inc., New York